Inactivation of glycogen synthase kinase 3β (GSK-3β) enhances skeletal muscle oxidative metabolism

被引：0
|
作者：
Remels, Alexander [1 ]
Verhees, Koen [1 ]
Gosker, Harry [1 ]
Schols, Annemie [1 ]
Langen, Ramon [1 ]
机构：
[1] Maastricht Univ, Med Ctr, NUTRIM Sch Nutr & Translat Res Metab, Resp Med, Maastricht, Netherlands
来源：
EUROPEAN RESPIRATORY JOURNAL | 2015年 / 46卷
关键词：
Peripheral muscle; Physical activity; COPD; -; mechanism;
D O I：
10.1183/13993003.congress-2015.PA1226
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
PA1226
引用
收藏
页数：2
相关论文
共 50 条
  • [41] 3-anilino-4-arylmaleimides: Potent and selective inhibitors of glycogen synthase kinase-3 (GSK-3)
    Smith, DG
    Buffet, M
    Fenwick, AE
    Haigh, D
    Ife, RJ
    Saunders, M
    Slingsby, BP
    Stacey, R
    Ward, RW
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2001, 11 (05) : 635 - 639
  • [42] Effects of a novel glycogen synthase kinase-3 (GSK-3) inhibitor on liver and muscle glycogen synthesis in awake ZDF (fa/fa) diabetic rats
    Cline, GW
    Johnson, K
    Regittnig, W
    Perret, P
    DIABETES, 2001, 50 : A325 - A325
  • [43] GSK-3β and control of glucose metabolism and insulin action in human skeletal muscle
    Ciaraldi, T. P.
    Carter, L.
    Mudaliar, S.
    Henry, R. R.
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2010, 315 (1-2) : 153 - 158
  • [44] Myogenic differentiation during regrowth of atrophied skeletal muscle is associated with inactivation of GSK-3β
    van der Velden, Jos L. J.
    Langen, Ramon C. J.
    Kelders, Marco C. J. M.
    Willems, Jodil
    Wouters, Emiel F. M.
    Janssen-Heininger, Yvonne M. W.
    Schols, Annemie M. W. J.
    AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2007, 292 (05): : C1636 - C1644
  • [45] Distribution of active glycogen synthase kinase 3β (GSK-3β) in brains staged for Alzheimer disease neurofibrillary changes
    Pei, JJ
    Braak, E
    Braak, H
    Grundke-Iqbal, I
    Iqbal, K
    Winblad, B
    Cowburn, RF
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1999, 58 (09): : 1010 - 1019
  • [46] Structure-based lead optimization of a novel glycogen synthase kinase 3 beta (GSK-3β) inhibitor
    Slater, Shuneize E.
    Fu, Gang
    Nael, Manal
    Avery, Mitchell A.
    Doerksen, Robert J.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 248
  • [47] Glycogen synthase kinase-3 beta (GSK-3/β) inhibitors as radioprotectors of hippocampal neurons in the developing brain
    Thotala, D.
    Hallahan, D. E.
    Yazlovitskaya, E. M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (03): : S124 - S125
  • [48] Inhibition by lithium of glycogen synthase kinase-3 (GSK-3): Possible mechanism of therapeutic action of lithium
    Herve, D.
    EUROPEAN PSYCHIATRY, 2014, 29 (08) : 669 - 670
  • [49] Characterization of Maleimide-Based Glycogen Synthase Kinase-3 (GSK-3) Inhibitors as Stimulators of Steroidogenesis
    Gunosewoyo, Hendra
    Midzak, Andrew
    Gaisina, Irina N.
    Sabath, Emily V.
    Fedolak, Allison
    Hanania, Taleen
    Brunner, Dani
    Papadopoulos, Vassilios
    Kozikowski, Alan P.
    JOURNAL OF MEDICINAL CHEMISTRY, 2013, 56 (12) : 5115 - 5129
  • [50] Glycogen synthase kinase 3 (GSK-3) inhibitors as new promising drugs for diabetes, neurodegeneration, cancer, and inflammation
    Martinez, A
    Castro, A
    Dorronsoro, I
    Alonso, M
    MEDICINAL RESEARCH REVIEWS, 2002, 22 (04) : 373 - 384
12345